[1] Kodali SK, Williams MR, Smith CR, et al.Two-year outcomes after transcatheter or surgical aortic-valve replacement[J]. N Engl J Med,2012,366(18):1686-1695.
[2] Strike E, Arklina B, Stradins P, et al.Postoperative pain management strategies and delirium after transapical aortic valve replacement: a randomized controlled trial[J]. J Cardiothorac Vasc Anesth,2019,33(6):1668-1672.
[3] Aronow WS, Ahn C, Kronzon I, et al.Prognosis of congestive heart failure in patients aged >or=62 years with unoperated severe valvular aortic stenosis[J]. Am J Cardiol,1993,72(11):846-848.
[4] Gersh BJ, Maron BJ, Bonow RO, et al.2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Am Coll Cardiol,2011, 58(25):e212-e260.
[5] 杨金保, 梁宏亮, 孟欣, 等. 改良Morrow手术治疗21例肥厚梗阻型心肌病临床分析[J]. 心脏杂志,2015,27(4):467-469.
[6] Rahimtoola SH.The problem of valve prosthesis-patient mismatch[J]. Circulation,1978,58(1):20-24.
[7] David TE, Armstrong S, Ivanov J, et al.Results of aortic valve sparing operations[J]. J Thorac Cardiovasc Surg,2001,122(1):39-46.
[8] Lababidi Z, Wu JR, Walls JT, et al.Percutaneous balloon aortic valvuloplasty: results in 23 patients[J]. Am J Cardiol,1984,53(1):194-197.
[9] Douglas PS, Leon MB, Mack MJ, et al.Longitudinal hemodynamics of transcatheter and surgical aortic valves in the PARTNER trial[J]. JAMA Cardiol,2017,2(11):1197-1206.
[10] Enezate TH, Kumar A, Fadel MA, et al.Transcatheter versus surgical aortic valve replacement in patients with non-high surgical risk severe aortic stenosis: A systematic review[J]. Cardiovasc Revasc Med,2017,18(5S1):S40-S48.
[11] Jones DA, Tchétché D, Forrest J, et al.The SURTAVI study: TAVI for patients with intermediate risk[J]. Euro-Intervention,2017,13(5):e617-e620. |
